skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 1,574  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: Journal Title: Hem/onc Today remove resource type: Articles remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Positive initial margins associated with poor DFS following total laryngectomy
Material Type:
Article
Add to My Research

Positive initial margins associated with poor DFS following total laryngectomy

HEM/ONC today, 2018-12, Vol.19 (24), p.57 [Peer Reviewed Journal]

ISSN: 1526-0488

Full text available

2
Intensified therapy improves outcomes for childhood B-cell ALL subgroup
Material Type:
Article
Add to My Research

Intensified therapy improves outcomes for childhood B-cell ALL subgroup

HEM/ONC today, 2018-11, Vol.19 (22), p.92-92 [Peer Reviewed Journal]

ISSN: 1526-0488

Full text available

3
Sorafenib plus transarterial chemoembolization improves PFS in unresectable HCC
Material Type:
Article
Add to My Research

Sorafenib plus transarterial chemoembolization improves PFS in unresectable HCC

HEM/ONC today, 2018-03, Vol.19 (5), p.30-30 [Peer Reviewed Journal]

ISSN: 1526-0488

Full text available

4
Myeloablative allogeneic HSCT associated with significant cognitive decline
Material Type:
Article
Add to My Research

Myeloablative allogeneic HSCT associated with significant cognitive decline

HEM/ONC today, 2018-03, Vol.19 (5), p.54-54 [Peer Reviewed Journal]

ISSN: 1526-0488

Full text available

5
Ruxolitinib shows promise against GVHD
Material Type:
Article
Add to My Research

Ruxolitinib shows promise against GVHD

HEM/ONC today, 2018-08, Vol.19 (15), p.50-50 [Peer Reviewed Journal]

ISSN: 1526-0488

Full text available

6
Ramucirumab improves response in urothelial cancer
Material Type:
Article
Add to My Research

Ramucirumab improves response in urothelial cancer

HEM/ONC today, 2018-05, Vol.19 (10), p.70-70 [Peer Reviewed Journal]

ISSN: 1526-0488

Full text available

7
Longer-term imatinib extends OS among patients with GIST
Material Type:
Article
Add to My Research

Longer-term imatinib extends OS among patients with GIST

HEM/ONC today, 2020-06, Vol.21 (12), p.18-18 [Peer Reviewed Journal]

Copyright SLACK INCORPORATED Jun 25, 2020 ;ISSN: 1526-0488

Full text available

8
Breast cancer stage, receptor status may help predict recurrence risk
Material Type:
Article
Add to My Research

Breast cancer stage, receptor status may help predict recurrence risk

HEM/ONC today, 2023-04, Vol.24 (4), p.18-18 [Peer Reviewed Journal]

Copyright SLACK INCORPORATED Apr 10, 2023 ;ISSN: 1526-0488

Full text available

9
Zanubrutinib improves outcomes in CLL, small lymphocytic lymphoma
Material Type:
Article
Add to My Research

Zanubrutinib improves outcomes in CLL, small lymphocytic lymphoma

HEM/ONC today, 2022-06, Vol.23 (8), p.18-18 [Peer Reviewed Journal]

Copyright SLACK INCORPORATED Jun 10, 2022 ;ISSN: 1526-0488

Full text available

10
Unrelated cord blood transplantation may be option for refractory severe aplastic anemia
Material Type:
Article
Add to My Research

Unrelated cord blood transplantation may be option for refractory severe aplastic anemia

HEM/ONC today, 2018-08, Vol.19 (16), p.59-59 [Peer Reviewed Journal]

ISSN: 1526-0488

Full text available

11
Long-term treatment-free remission achievable for CML
Material Type:
Article
Add to My Research

Long-term treatment-free remission achievable for CML

HEM/ONC today, 2018-07, Vol.19 (13), p.28-29 [Peer Reviewed Journal]

Copyright SLACK INCORPORATED Jul 10, 2018 ;ISSN: 1526-0488

Full text available

12
Encorafenib plus binimetinib prolongs OS for advanced BRAF-mutated melanoma
Material Type:
Article
Add to My Research

Encorafenib plus binimetinib prolongs OS for advanced BRAF-mutated melanoma

HEM/ONC today, 2018-06, Vol.19 (12), p.26-28 [Peer Reviewed Journal]

ISSN: 1526-0488

Full text available

13
Encorafenib plus binimetinib prolongs PFS in BRAF-mutated advanced melanoma
Material Type:
Article
Add to My Research

Encorafenib plus binimetinib prolongs PFS in BRAF-mutated advanced melanoma

HEM/ONC today, 2018-05, Vol.19 (10), p.66-67 [Peer Reviewed Journal]

ISSN: 1526-0488

Full text available

14
SGX301 induces response in cutaneous T-cell lymphoma
Material Type:
Article
Add to My Research

SGX301 induces response in cutaneous T-cell lymphoma

HEM/ONC today, 2020-04, Vol.21 (8), p.38-38 [Peer Reviewed Journal]

Copyright SLACK INCORPORATED Apr 25, 2020 ;ISSN: 1526-0488

Full text available

15
OS rate for Hodgkin lymphoma remains high with PET response-adapted therapy
Material Type:
Article
Add to My Research

OS rate for Hodgkin lymphoma remains high with PET response-adapted therapy

HEM/ONC today, 2019-11, Vol.20 (22), p.65-65 [Peer Reviewed Journal]

Copyright SLACK INCORPORATED Nov 25, 2019 ;ISSN: 1526-0488

Full text available

16
Adjuvant imatinib shows modest benefit for high-risk gastrointestinal stromal tumors
Material Type:
Article
Add to My Research

Adjuvant imatinib shows modest benefit for high-risk gastrointestinal stromal tumors

HEM/ONC today, 2017-10, Vol.18 (20), p.31-31 [Peer Reviewed Journal]

Copyright SLACK INCORPORATED Oct 25, 2017 ;ISSN: 1526-0488

Full text available

17
Adjuvant vemurafenib increases DFS in resected BRAF V600-positive melanoma
Material Type:
Article
Add to My Research

Adjuvant vemurafenib increases DFS in resected BRAF V600-positive melanoma

HEM/ONC today, 2017-10, Vol.18 (20), p.46-46 [Peer Reviewed Journal]

ISSN: 1526-0488

Full text available

18
Asciminib effective, safe as late-line treatment for chronic-phase CML
Material Type:
Article
Add to My Research

Asciminib effective, safe as late-line treatment for chronic-phase CML

HEM/ONC today, 2021-02, Vol.22 (2), p.38-38 [Peer Reviewed Journal]

Copyright SLACK INCORPORATED Feb 2021 ;ISSN: 1526-0488

Full text available

19
Robotic lier resection safe, effectie for hepatocellular carcinoma
Material Type:
Article
Add to My Research

Robotic lier resection safe, effectie for hepatocellular carcinoma

HEM/ONC today, 2023-01, Vol.24 (1), p.30-30 [Peer Reviewed Journal]

Copyright SLACK INCORPORATED Jan 2023 ;ISSN: 1526-0488

Full text available

20
Low-dose tamoxifen confers sustained reduction in recurrence risk in noninasie breast cancer
Material Type:
Article
Add to My Research

Low-dose tamoxifen confers sustained reduction in recurrence risk in noninasie breast cancer

HEM/ONC today, 2023-01, Vol.24 (1), p.26-27 [Peer Reviewed Journal]

Copyright SLACK INCORPORATED Jan 2023 ;ISSN: 1526-0488

Full text available

Results 1 - 20 of 1,574  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2017  (1)
  2. 2017 To 2017  (418)
  3. 2018 To 2018  (593)
  4. 2019 To 2020  (494)
  5. After 2020  (69)
  6. More options open sub menu

Searching Remote Databases, Please Wait